Our findings align with these previous observations, further supporting the potential of LSD1 inhibitors to ameliorate a range of behavioral and cognitive dysfunctions associated with neurodevelopmental and psychiatric disorders. The gene discussed is KDM1A; the disease is psychiatric disorder.